Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Autonomix Medical Inc (AMIX)

Autonomix Medical Inc (AMIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Public Offering of Common Stock Units and Pre-Funded Warrant Units Quiver Quantitative, Inc. - Fri Nov 22, 6:24PM CST

Autonomix Medical announces $9 million stock offering to fund clinical trials and research for innovative nerve-targeted treatments.Quiver AI SummaryAutonomix Medical, Inc. has announced a public offering...

AMIX : 6.28 (-53.55%)
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering GlobeNewswire - Fri Nov 22, 8:15AM CST

AMIX : 6.28 (-53.55%)
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update GlobeNewswire - Mon Nov 11, 7:00AM CST

AMIX : 6.28 (-53.55%)
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction GlobeNewswire - Thu Oct 31, 7:00AM CDT

AMIX : 6.28 (-53.55%)
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial GlobeNewswire - Wed Oct 30, 7:30AM CDT

AMIX : 6.28 (-53.55%)
Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial GlobeNewswire - Mon Oct 28, 7:00AM CDT

AMIX : 6.28 (-53.55%)
Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th GlobeNewswire - Fri Oct 25, 10:30AM CDT

AMIX : 6.28 (-53.55%)
Autonomix Announces Reverse Stock Split GlobeNewswire - Tue Oct 22, 7:30AM CDT

AMIX : 6.28 (-53.55%)
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC GlobeNewswire - Tue Oct 8, 7:30AM CDT

AMIX : 6.28 (-53.55%)

Barchart Exclusives

3 High-Yielding Dividend Kings to Boost Your Income in 2025 and Beyond Barchart - Fri Nov 22, 6:00PM CST
These three high-quality companies are currently on sale, offering elevated yields that appeal to dividend growth investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot